ACPE Numbers: Various – see listing below
Pre-Sale Date: 10/28/2020
Content Release Date: 11/25/2020
Expiration Date: 11/23/2021
Activity Type: Application-based
CE Credits: 5.0 hours (BPS and ACPE)
Activity Fee: $100 (ASHP member); $150 (non-member)
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
These activities are intended for Board Certified Pharmacotherapy Specialists in need of recertification credit.
The Core Therapeutic Modules for Recertification Package consists of 5 activities (see table below). In each activity, faculty review clinical topics and practice skills using a case-based approach. This package is intended for board certified pharmacists in need of recertification credit; the activities were designed based on the content outline developed by the Board of Pharmacy Specialties (BPS).
Each activity is approved for 1.0 hour of continuing pharmacy education credit. Successful completion of all the learning modules will provide up to 5.0 hours of continuing pharmacy education credit.
Board certified pharmacists are eligible to receive 5.0 hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessment by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
Participants who pass the assessments will be eligible for recertification credit in the year in which the assessment was completed.
These activities are part of the ASHP professional development program for BCPS recertification approved by the BPS.
*Assessment Pass Point
Cardiac Arrhythmias and Advanced Cardiac Life Support
Pharmacotherapy Considerations in the Management of Shock
Select Topics in Men's Health
Select Topics in Women's Health
Select Topics in Gastrointestinal Diseases
ACPE number: 0204-0000-20-992-H01-P
- Interpret signs, symptoms and diagnostic tests for cardiac arrhythmias.
- Identify drug-related problems, including drug interactions and adverse effects, associated with pharmacotherapy of cardiac arrhythmias.
- Identify strategies to prevent drug-induced cardiac arrhythmias.
- Recommend therapy and monitoring for cardiac arrhythmias based on patient-specific information, current guidelines and Advanced Cardiac Life Support (ACLS) guided therapies.
ACPE number: 0204-0000-20-993-H01-P
- Interpret diagnostic and/or laboratory tests, vital signs, and clinical presentation in order to differentiate types of shock (hypovolemic, distributive, cardiogenic).
- Compare and contrast the pharmacologic agents utilized in shock.
- Recommend the most appropriate therapy and monitoring based on patient-specific information and current guidelines for the treatment of shock.
ACPE number: 0204-0000-20-615-H01-P
- Recommend appropriate treatment, monitoring and follow-up plans based on patient-specific information and current guidelines for patients with benign prostatic hyperplasia, erectile dysfunction and testosterone deficiency.
- Explain screening and treatment of osteoporosis in men.
- Evaluate the role of prostate cancer screening.
- Select appropriate treatment for patients with prostate cancer.
ACPE number: 0204-0000-20-616-H01-P
- Describe pertinent sex-based differences in pharmacodynamics and pharmacokinetics that affect exposure and response to medications.
- Select health screenings based on patient-specific information for osteoporosis, breast cancer, endometrial cancer, and cervical cancer.
- Recommend appropriate treatment, monitoring and follow-up plans based on patient-specific information and current guidelines for osteoporosis and menopausal symptoms.
- Select appropriate contraceptive options, including emergency contraception, based on patient-specific information.
- Evaluate safety and efficacy of common therapies used during pregnancy and lactation.
ACPE number: 0204-0000-20-617-H01-P
- For patients with nausea, vomiting, inflammatory bowel disease, gastroesophageal reflux disease, or peptic ulcer disease:
- Recommend appropriate treatment and monitoring, based on drug-specific variables, patient-specific information and clinical practice guidelines.
- Evaluate drug-related problems and response to therapy.
- Recommend modifications of patient-specific treatment plans based on follow up assessment.
Planners, Presenters, and Reviewers
Clinical Pharmacy Specialist - Medical Oncology
Emory Healthcare - Winship Cancer Institute
Assistant Professor of Pharmacy Practice
Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy
Clinical Pharmacy Specialists, Geriatrics and Extended Care
VA North Texas Health Care System
Assistant Professor of Clinical Pharmacy
Philadelphia College of Pharmacy, University of the Sciences
Clinical Pharmacy Specialist - Ambulatory Care
Cooper University Hospital
Camden, New Jersey
Clinical Specialist, Emergency Medicine
Mercy Health Saint Mary's
Grand Rapids, Michigan
Assistant Clinical Professor
Auburn University Harrison School of Pharmacy
Clinical Pharmacy Practice Manager
Brigham and Women's Hospital
Sullivan University College of Pharmacy
Cardiology Clinical Pharmacy Specialist
Jewish Hospital Rudd Heart and Lung Center
Massachusetts College of Pharmacy and Health Science
Beth Israel Deaconess Medical Center
Philadelphia College of Pharmacy at University of the Sciences
Clinical Pharmacy Specialist
Cooper University Hospital
Camden, New Jersey
Professor, Pharmacy Practice
Jefferson College of Pharmacy
West Virginia University (WVU) and WVU Hospitals and Clinics
Anna M. Jackson, Pharm.D., BCPS
Tony Martin, Pharm.D., M.B.A.
Susan R. Dombrowski, M.S., R.Ph.
Merlin Alexander, Pharm.D., BCPS
Macayla Bartucca, Pharm.D.
Sarah Benner, Pharm.D., BCPS, BCPP
Zachary Brent, Pharm.D., BCPS
Heng Chang, Pharm.D., BCPS
Judy Chennat, Pharm.D, BCPS
Diana Cowell, Pharm.D., BCPS
Lydia D'Agostino, Pharm.D., BCPS, BCIDP
Tara Driscoll, Pharm.D., BCPS, BCACP
Tara Feller, Pharm.D., M.B.A., MPH, BCPS
Kisha Gant, Pharm.D., BCACP, BCGP, BCPS
Catlin Grisham-Takac, Pharm.D., BCPS
Laura Hart, Pharm.D., M.S., BCPS, BCGP
Michele Havens, Pharm.D, BCPS
Elham Hekmat, Pharm.D., BCPS
Lindsey Hunt, Pharm.D., BCPS
Kimberly Johnson, Pharm.D.,BCPS
claire kestenbaum, Pharm. D., BCPS
Serena Key-Tate, Pharm.D., BCPS, BCSCP
jessen Koshy, Pharm.D. BCPS
Lauren Leedom, BS,BCPS,M.B.A.
Areerut Leelathanalerk, Pharm.D., BCPS
Jamie Longmire, Pharm.D., BCPS
Laura MacCall, Pharm.D., BCPS
Melanie Madorsky, Pharm.D., BCPS, BCCP
Chinwe Mbonu, Pharm.D., BCPS
Mallory McCullough, Pharm.D., BCPS
Scott McDougall, Bsc Pharm, BCPS
Michael McQuade, Pharm.D., BCCCP, BCPS
Amanda McQuillan, Pharm.D., BCPS, BCPP
Sarah Michienzi, Pharm.D., BCPS, AAHIVP
Ana Miladinovic, Pharm.D.,BCPS
Jessica Moschea, Pharm.D., BCPS
Ijang Ngando, Pharm.D., M.B.A., BCPS, BCCCP
Ramat Aderemi Omole, Pharm D., M.Sc., BCPS, CPH
Liz Palmer, Pharm.D., BCPS
Nisha Patel, Pharm.D., M.B.A., BCPS
Kerry Anne Rambaran, Pharm.D., BCPS
Mohammad Rattu, Pharm.D., BCOP, BCPS, BCGP
Heather Redden, Pharm.D.
Amy Richardson, Pharm.D., BCPS
Brooke Roe, Pharm.D.
Hollins Schwantes, Pharm.D., BCCCP, BCPS
Gita Soltani, Pharm D
Conner Sothoron, Pharm.D.., BCPS, BCCCP
Stacia Street, Pharm.D., BCPS
Marisa Strychalski, Pharm.D., BCPS, BCACP
Florence Tan, Pharm.D., BCPS, BCGP
Alison Tonsk, Pharm.D., BCPS, BCGP
Aiwen Wang, Pharm.D.
Corrie Weiland, Pharm.D., BCPS
Max Whitney, Pharm.D., BCCCP, BCPS
Robert Wood, Pharm.D., BCPS
Kelsie Young, Pharm.D.,BCPS
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.
All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.
- Snehal Bhatt, Pharm.D., BCPS, Portola Pharmaceuticals - Advisory Board; Janssen Pharmaceuticals, Inc. - Speaker Bureau
- All other planners, presenters, and reviewers of this session report no financial relationships relevant to this activity.
Methods and CE Requirements
Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
System Technical Requirements
Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.
View the minimum technical and system requirements for learning activities.
These activities were developed by ASHP.